Someone gets diagnosed with Multiple Sclerosis every five minutes around the world. This makes stem cell treatment for PPMS (Primary Progressive Multiple Sclerosis) one of the most important areas of medical progress today. PPMS, a specific type of MS that affects the central nervous system, impacts thousands of lives with its progressive nature and challenging symptoms. New developments in stem cell therapy bring fresh hope to patients looking for effective treatments to beat MS and improve their quality of life.
Colombia’s stem cell therapy costs between $6,900 and $11,000, which is significantly cheaper than the $50,000 patients pay in the United States. Regencord’s specialists use mesenchymal stem cells to repair and regenerate damaged myelin sheath cells in the central nervous system. Patients usually see their PPMS symptoms improve within 3-6 months after treatment. This innovative treatment slows down the disease progression and improves the patient’s quality of life through a tailored treatment plan.
“Stem cell therapy has emerged as a promising alternative treatment for PPMS, offering hope to those who struggle with the disease’s relentless progression.” — Dr. Jeffery Weiss, Stem Cell Therapy Expert and Founder of DVC Stem
Primary Progressive Multiple Sclerosis (PPMS) creates unique challenges that make it different from other forms of MS. Stem cell therapy has become a valuable treatment option for patients who need effective solutions to address their PPMS symptoms and potentially improve their PPMS life expectancy.
PPMS stands apart from relapsing forms of MS. Patients experience steadily worsening neurological function without clear relapses or remissions. This rare form affects only 10-15% of all MS patients. Their symptoms lead to steadily increasing disability right from the start, which significantly impacts PPMS prognosis.
PPMS has several unique features that make treatment challenging. The disease affects men and women in equal numbers, unlike other MS types that mostly affect women. People usually get their diagnosis in their 40s rather than their 30s. PPMS patients show fewer brain lesions but more spinal cord damage. This leads to significant mobility issues and walking difficulties.
The disease works differently at its core. PPMS shows much less inflammation than relapsing forms. MRI scans reveal minimal inflammatory activity. The disease focuses on nerve cell degeneration and axonal degeneration instead of inflammation. This makes standard treatments less effective and necessitates new approaches to beat MS.
PPMS treatment options lag behind other MS types. More than 20 disease-modifying therapies exist for relapsing MS forms. However, only one FDA-approved treatment—ocrelizumab (Ocrevus)—has specific approval for PPMS. This treatment targets B cells and slows down clinical disability accumulation by about 25%. Many patients still see their disability get worse even with treatment.
Research shows many PPMS patients receive no treatment, especially those with non-active disease. Between 2018 and 2021, about 10-38% of PPMS patients didn't get any disease-modifying treatment. Doctors say the biggest challenge is finding meds used to treat MS that effectively slow disease progression and address the unique aspects of PPMS.
Stem cell therapy shows promise by targeting why PPMS causes nerve degeneration. Traditional medications focus on reducing inflammation, but stem cell treatments aim to repair tissue and provide neuroprotection through multiple approaches.
Different types of stem cell therapy could help PPMS patients. Hematopoietic stem cell transplantation (HSCT) resets the immune system through immunoablation and rebuilding. This works best when active inflammation exists.
Mesenchymal stem cells (MSCs) look particularly promising for progressive MS treatment. These cells can modify immune responses and help with tissue regeneration. They work by releasing factors that offer nerve cell protection and promote remyelination. MSCs have shown anti-inflammatory properties and the potential for myelin repair, addressing key aspects of PPMS pathology.
Places like Regencord Pereira customize stem cell treatment protocols to address PPMS's unique challenges. This offers hope where traditional therapies don't work very well. The use of mesenchymal stem cells, particularly those derived from umbilical cord cells, has shown promising results in MS stem cell therapy.
A PPMS diagnosis starts an emotional trip that goes way beyond the clinical reality of the condition. The path from your original diagnosis to treatment decisions requires you to process complex emotions. You must research extensively and face your fears about new treatments for PPMS.
A PPMS diagnosis brings out different emotional responses. Many people feel overwhelmed, frightened, and deeply distressed when confronted with the reality of what PPMS is and its potential impact on their lives.
Some find relief after months or years of unexplained neurological symptoms. Others shut down emotionally to protect themselves from the implications of their PPMS prognosis.
The emotional process works like a roller coaster ride. Fear and anticipation come first. Then you realize there's no turning back. Patients go through ups and downs as they adjust to their new reality. Everyone's trip is unique. There's no right or wrong way to react to learning about your PPMS life expectancy and the challenges ahead.
Patients and their loved ones often process the diagnosis differently. To cite an instance, a patient might feel relief while their partner stays in denial. About 20% of PPMS patients deal with depression. Yet less than 10% get psychological support. This shows how much emotional care matters in managing PPMS symptoms and overall well-being.
Patients start looking into treatment options after dealing with their original emotions. They often find that regular treatments have big limits for PPMS. Research shows common symptoms like pain, ataxia, and bladder disorders stay untreated in 52-71% of patients, highlighting the need for new MS medication in 2023 and beyond.
This reality guides patients to explore new approaches like stem cell therapy. Mesenchymal stem cells (MSCs) show real promise in stem cell research for MS. Studies reveal that 40.4% of MS patients expressed improvements after MSC therapy, while 32.8% stayed stable. MSCs from the umbilical cord or placenta work better than bone-marrow-derived MSCs for MS stem cell therapy. The improvement rates stand at 56.7% versus 38.5%.
Finding specialized facilities like Regencord Pereira marks a turning point in this research phase. Their expertise in stem cell treatments for PPMS creates a path toward possible improvement and offers a new treatment for PPMS that addresses the underlying mechanisms of the disease.
The fear of getting fake treatments tops the list of common concerns. In fact, some dishonest clinics exploit vulnerable patients. They use unproven therapies that lack scientific backing or oversight, which is why it's crucial to distinguish legitimate MS clinical trials and treatments from unproven alternatives.
Mental barriers create challenges, too. Patients worry about stem cells causing cancer or genetic mutations. Money adds more stress. Stem cell therapies can get pricey even though Colombia offers more affordable options than the United States. While some may search for a "stem cell boosting pill" or "stem cell pills" as an easier alternative, it's important to note that legitimate stem cell therapies typically involve more complex procedures.
Education and mental preparation help overcome these fears. Good facilities give you a full picture of treatment procedures, potential risks, and realistic expectations. The right mental assessment before treatment matters a lot. Depression, anxiety, or stress without treatment can seriously affect your outcomes and overall ability to beat MS.
Regencord Pereira offers stem cell treatment with a well-laid-out therapeutic experience designed for PPMS patients. This 11-year-old facility has treated more than 5,000 patients and developed a complete protocol for patients looking for trailblazing solutions in progressive MS treatment.
Your experience at Regencord starts with a detailed consultation to check if you’re right for the treatment. Doctors will get a full picture of your medical history, conduct a physical examination, and review diagnostic imaging to assess your condition’s severity. Specialists in genetics, biotechnology, and pharmacology bring over 30 years of combined experience to create your custom treatment plan.
Doctors design each treatment plan around your specific needs and pay special attention to PPMS challenges. This assessment helps them find the right mesenchymal stem cell dosages that work best while staying safe. Patients learn about how stem cell therapy works and what results they can realistically expect in terms of managing PPMS symptoms and potentially improving their PPMS prognosis.
Regencord handles stem cell harvesting and processing in their laboratory after your consultation. The facility meets the highest quality standards with multiple ISO certifications: ISO 9001 for management systems, ISO 13022 for risk management, ISO 14644 for air cleanliness, and ISO 22859 for biobanking.
The core team at the laboratory includes geneticists, physician pharmacologists, biologists, biotechnologists, and bacteriologists. They use specialized technology to ensure all cell products meet strict quality and safety protocols. Every batch goes through multiple safety checks, and quality certificates track the entire production process. This rigorous approach ensures the highest standards for mesenchymal stem cells used in treatment.
The treatment process is simple and quick on the day of your procedure. Your stem cells might be given through:
Medical staff watch your vital signs carefully during the procedure. They check your heart rate, blood pressure, breathing rate, and oxygen levels. You'll stay under observation after treatment until the team is sure you're ready to go home.
The whole ordeal takes just a few days, and the actual stem cell treatment finishes within hours. The results speak for themselves - 95% of patients report positive outcomes without serious side effects. Regencord's approach gives PPMS patients a promising and reassuring option for stem cell treatment that addresses inflammation, oxidative stress, and promotes neuroprotection in the central nervous system.
“A sizable number of case series, uncontrolled phase 2 clinical trials, and randomized clinical trials have demonstrated, in the aggregate, potent efficacy of AHSCT in patients with active relapsing MS, including a marked reduction in relapses, MRI lesion activity, and brain volume loss (after initial acceleration).” — Cleveland Clinic, Mellon Center for Multiple Sclerosis Treatment and Research
Stem cell therapy patients start their recovery path right after treatment. This critical phase includes careful monitoring and customized follow-up care for PPMS patients, focusing on tracking improvements in PPMS symptoms and overall disease progression.
Patients need rest and close monitoring in the days after stem cell therapy. Some patients might experience mild side effects such as fever, headache, or urinary tract infection.
Studies show that stem cell therapy affects patients differently. About 40.4% of MS patients see improvements, 32.8% remain stable, and 18.1% experience worsening conditions. The most promising improvements include:
Benefits can appear quickly or develop over time. Short-term results (≤6 months) reveal that 45.8% of patients improve and 35.6% maintain their condition. These improvements are attributed to the immunomodulation and tissue regeneration properties of mesenchymal stem cells, which help address inflammation and promote remyelination in the central nervous system.
Regular follow-up care helps maintain treatment benefits. Regencord's medical team stays connected with patients for at least one year after treatment. The first check-up happens at 3 months, with more visits scheduled based on the doctor's advice. These outpatient visits last 2-3 days and include blood tests, neurological exams, therapy adjustments, and future care plans.
Doctors monitor neurological function through clinical visits and regular MRIs, which aligns with standard MS care. About 43% of patients show better disability scores, while 34% maintain their condition over two years. Doctors assess progress continuously and might suggest additional therapies or lifestyle changes to boost treatment results. This comprehensive approach aims to maximize the benefits of stem cell therapy and improve the overall PPMS prognosis for patients.
Stem cell therapy, particularly using mesenchymal stem cells, is a breakthrough treatment option for PPMS patients at specialized facilities like Regencord Pereira. The facility’s detailed approach combines advanced laboratory facilities with experienced medical professionals to give new hope to patients who need effective PPMS management and are looking to beat MS.
Studies show the most important positive outcomes. More than 40% of patients see improvements, and a third maintain stable conditions. Colombian stem cell therapy costs less than U.S. alternatives, which makes it an appealing choice for many PPMS patients seeking new treatments for PPMS.
Patient success stories show the possible benefits, though each patient’s recovery is different. Regencord Pereira’s team guides patients through their recovery with careful monitoring, tailored treatment plans, and dedicated follow-up care. While stem cell therapy may not completely cure PPMS, it helps manage symptoms and might slow down the disease’s progression by addressing key aspects like inflammation, oxidative stress, and promoting neuroprotection and remyelination in the central nervous system. Schedule a consultation with Regencord and experience the difference!
3-Step Process for Stem Cell Treatment for Arthritis in Hands
Stem cells are unique cells with the ability to develop into various cell types and repair damaged tissues. They are used in regenerative medicine, including treatments for cancer, neurodegenerative diseases, and injuries. Sources include bone marrow, cord blood, and embryos.
(888) 540-4101
Begin your journey with us today! Call us at (888) 540-4101 or complete the form to learn more.